[Re: Prostaglandin E1 for prevention of contrast medium-induced kidney dysfunction. Fortsch Röntgenstr 170 (1999) 557-563].
Fröhlich
J
J
D058186:Acute Kidney Injury / Q000517:prevention & control*; D000527:Alprostadil / Q000008:administration & dosage* / Q000494:pharmacology; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D018849:Controlled Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008962:Models, Theoretical; D015337:Multicenter Studies as Topic; D010865:Pilot Projects; D011446:Prospective Studies; D012307:Risk Factors; D013997:Time Factors
D003287:Contrast Media; D003404:Creatinine; D000527:Alprostadil
Zu: Prostaglandin E1 zur Prophylaxe kontrastmittelinduzierter Nierenfunktionsstörungen. In: Fortschr Röntgenstr 170 (1999) 557-563.